Amplification of DNA copy number (63.4%; n = 52/82) followed by mRNA overexpression (72%; n = 59/82) of EPAS1 tissues implies its cancer‐promoting properties in patients with CRC. The gene discussed is EPAS1; the disease is colorectal carcinoma.